Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $124.81 USD
Change Today -0.07 / -0.06%
Volume 378.2K
ALNY On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
John Clarke 90 RelationshipsFounder, Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeTop Key Executive60
John Maraganore M.D., Ph.D.171 RelationshipsChief Executive Officer and Executive DirectorChief Executive Officer51

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Phillip Sharp Ph.D. 174 RelationshipsMember of the Board of DirectorsAmerican Association for the Advancement of Science69
Kevin Starr 88 RelationshipsMember of the Board of DirectorsThird Rock Ventures, LLC51
Steven Paul M.D. 121 RelationshipsMember of the Board of DirectorsSage Therapeutics, Inc.63
Paul Schimmel Ph.D. 94 RelationshipsMember of the Board of DirectorsaTyr Pharma Inc.73
Thomas Tuschl Ph.D. 25 RelationshipsMember of Advisory BoardAlnylam Pharmaceuticals, Inc.--
Phillip Zamore Ph.D. 16 RelationshipsMember of Advisory BoardVoyager Therapeutics, Inc.--
Markus Stoffel M.D., Ph.D. 26 RelationshipsMember of Advisory BoardPanCel Corporation--
Robert Langer Jr., Ph.D., Sc.D 453 RelationshipsMember of Advisory BoardBIND Therapeutics, Inc.66
David Bartel Ph.D. 28 RelationshipsMember of Advisory BoardRegulus Therapeutics Inc.--
Dennis Ausiello M.D. 86 RelationshipsMember of the Board of DirectorsProventys, Inc.68
Judy Lieberman M.D., Ph.D. 24 RelationshipsMember of Advisory BoardAlnylam Pharmaceuticals, Inc.--
Marsha Fanucci 62 RelationshipsMember of the Board of DirectorsMomenta Pharmaceuticals Inc.60
Daniel Rader M.D., FAHA 48 RelationshipsMember of Advisory BoardVascular Strategies LLC--
Amy Schulman J.D. 132 RelationshipsMember of the Board of DirectorsArsia Therapeutics, Inc.53
Michael Bonney B.A. 30 RelationshipsMember of the Board of DirectorsCalixa Therapeutics, Inc.56
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNY:US $124.81 USD -0.07

ALNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Benitec Biopharma Ltd A$0.77 AUD -0.035
Enzon Pharmaceuticals Inc $1.22 USD 0.00
Marina Biotech Inc $0.52 USD 0.00
Silence Therapeutics PLC 310.00 GBp +5.00
View Industry Companies
 

Industry Analysis

ALNY

Industry Average

Valuation ALNY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 168.4x
Price/Book 7.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 155.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALNYLAM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.